Viewing Study NCT06591572



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06591572
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-11

Brief Title: Single-port Robotic Versus Laparoscopic Transanal Total Mesorectal Excision
Sponsor: None
Organization: None

Study Overview

Official Title: Efficacy and Safety Assessment of Single-port Robotic Versus Laparoscopic Transanal Total Mesorectal Excision for Mid and Low Rectal Cancer a Phase 2a Prospective Cohort Study Based on the IDEAL Framework
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a phase 2a clinical trial based on the IDEAL framework to evaluate the safety feasibility and clinical efficacy of Single-port robotic transanal total mesorectal excision SPr-taTME surgery The intraoperative complications postoperative complications perioperative recovery effects quality of surgical specimens pathological indexes and oncology effects of SPr-taTME and laparoscopic transanal total mesorectal excision L-taTME in the treatment of middle and low rectal cancer were compared
Detailed Description: The intraoperative complications postoperative complications perioperative recovery effects quality of surgical specimens pathological indexes and oncology effects of SPr-taTME and laparoscopic transanal total mesorectal excision L-taTME in the treatment of middle and low rectal cancer were compared

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None